Decision Diagnostics Corp. (DECN)
USD 0.0
(9900.0%)
USD 0.0
(9900.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 2.81 Million USD | 0.81% |
| 2019 | 2.79 Million USD | 82.58% |
| 2018 | 1.53 Million USD | -24.56% |
| 2017 | 2.02 Million USD | -11.84% |
| 2016 | 2.3 Million USD | 117.1% |
| 2015 | 1.06 Million USD | 0.0% |
| 2012 | 2.46 Million USD | 13.39% |
| 2011 | 2.17 Million USD | -0.66% |
| 2010 | 2.18 Million USD | -3.15% |
| 2009 | 2.26 Million USD | -29.87% |
| 2008 | 3.22 Million USD | 52.68% |
| 2007 | 2.11 Million USD | 19.58% |
| 2006 | 1.76 Million USD | 25.78% |
| 2005 | 1.4 Million USD | 72.7% |
| 2004 | 812.71 Thousand USD | 21.0% |
| 2003 | 671.67 Thousand USD | 35.39% |
| 2002 | 496.1 Thousand USD | -58.66% |
| 2001 | 1.2 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 2.92 Million USD | 3.67% |
| 2021 Q2 | 3.14 Million USD | 7.58% |
| 2021 Q3 | 3.23 Million USD | 3.03% |
| 2020 Q4 | 2.81 Million USD | -16.33% |
| 2020 FY | 2.81 Million USD | 0.81% |
| 2020 Q2 | 2.89 Million USD | -19.18% |
| 2020 Q3 | 3.36 Million USD | 16.38% |
| 2020 Q1 | 3.57 Million USD | 28.1% |
| 2019 FY | 2.79 Million USD | 82.58% |
| 2019 Q2 | 1.09 Million USD | -35.45% |
| 2019 Q3 | 1.11 Million USD | 1.82% |
| 2019 Q4 | 2.79 Million USD | 150.2% |
| 2019 Q1 | 1.69 Million USD | 11.02% |
| 2018 Q4 | 1.53 Million USD | 2.98% |
| 2018 FY | 1.53 Million USD | -24.56% |
| 2018 Q1 | 1.58 Million USD | -22.12% |
| 2018 Q2 | 1.4 Million USD | -11.27% |
| 2018 Q3 | 1.48 Million USD | 6.0% |
| 2017 Q3 | 2.25 Million USD | 0.0% |
| 2017 Q1 | 1.99 Million USD | -13.29% |
| 2017 FY | 2.02 Million USD | -11.84% |
| 2017 Q4 | 2.02 Million USD | -10.0% |
| 2016 Q1 | 1.33 Million USD | 25.94% |
| 2016 FY | 2.3 Million USD | 117.1% |
| 2016 Q4 | 2.3 Million USD | 7.69% |
| 2016 Q3 | 2.13 Million USD | 14.98% |
| 2016 Q2 | 1.85 Million USD | 39.23% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q4 | 1.06 Million USD | 0.0% |
| 2015 Q1 | 2.47 Million USD | 0.0% |
| 2015 Q2 | 2.26 Million USD | -8.4% |
| 2015 FY | 1.06 Million USD | 0.0% |
| 2013 Q1 | 2.76 Million USD | 12.31% |
| 2013 Q3 | 3.09 Million USD | 5.72% |
| 2013 Q2 | 2.92 Million USD | 5.7% |
| 2012 Q1 | 2.17 Million USD | 0.0% |
| 2012 Q2 | 2.29 Million USD | 5.61% |
| 2012 Q3 | 2.45 Million USD | 6.72% |
| 2012 Q4 | 2.46 Million USD | 0.61% |
| 2012 FY | 2.46 Million USD | 13.39% |
| 2011 Q4 | 2.17 Million USD | 3.76% |
| 2011 Q2 | 1.85 Million USD | 885.71% |
| 2011 FY | 2.17 Million USD | -0.66% |
| 2011 Q1 | 188.41 Thousand USD | -91.39% |
| 2011 Q3 | 2.09 Million USD | 12.86% |
| 2010 FY | 2.18 Million USD | -3.15% |
| 2010 Q1 | 1.35 Million USD | -39.84% |
| 2010 Q2 | 1.43 Million USD | 5.88% |
| 2010 Q3 | 1.09 Million USD | -23.83% |
| 2010 Q4 | 2.18 Million USD | 99.61% |
| 2009 Q4 | 2.26 Million USD | 19.28% |
| 2009 Q1 | 2.72 Million USD | -15.48% |
| 2009 FY | 2.26 Million USD | -29.87% |
| 2009 Q2 | 2.35 Million USD | -13.64% |
| 2009 Q3 | 1.89 Million USD | -19.45% |
| 2008 FY | 3.22 Million USD | 52.68% |
| 2008 Q1 | 2.15 Million USD | 2.13% |
| 2008 Q2 | 2.28 Million USD | 5.8% |
| 2008 Q3 | 2.47 Million USD | 8.67% |
| 2008 Q4 | 3.22 Million USD | 30.03% |
| 2007 FY | 2.11 Million USD | 19.58% |
| 2007 Q2 | 1.81 Million USD | 13.55% |
| 2007 Q1 | 1.59 Million USD | -9.41% |
| 2007 Q3 | 1.6 Million USD | -11.39% |
| 2007 Q4 | 2.11 Million USD | 31.2% |
| 2006 FY | 1.76 Million USD | 25.78% |
| 2006 Q4 | 1.76 Million USD | 5.8% |
| 2006 Q3 | 1.66 Million USD | 11.79% |
| 2006 Q1 | 1.36 Million USD | -2.75% |
| 2006 Q2 | 1.49 Million USD | 9.35% |
| 2005 Q1 | 1.31 Million USD | 61.93% |
| 2005 Q4 | 1.4 Million USD | 15.7% |
| 2005 Q3 | 1.21 Million USD | 10.27% |
| 2005 Q2 | 1.1 Million USD | -16.41% |
| 2005 FY | 1.4 Million USD | 72.7% |
| 2004 FY | 812.71 Thousand USD | 21.0% |
| 2004 Q4 | 812.71 Thousand USD | 14.29% |
| 2004 Q3 | 711.11 Thousand USD | -9.34% |
| 2004 Q2 | 784.36 Thousand USD | -15.52% |
| 2004 Q1 | 928.51 Thousand USD | 38.24% |
| 2003 Q2 | 660.72 Thousand USD | 11.23% |
| 2003 FY | 671.67 Thousand USD | 35.39% |
| 2003 Q4 | 671.67 Thousand USD | 11.09% |
| 2003 Q1 | 594.02 Thousand USD | 19.74% |
| 2003 Q3 | 604.6 Thousand USD | -8.49% |
| 2002 Q2 | 577.57 Thousand USD | -52.64% |
| 2002 Q1 | 1.21 Million USD | 0.0% |
| 2002 FY | 496.1 Thousand USD | -58.66% |
| 2002 Q3 | 485.41 Thousand USD | -15.96% |
| 2002 Q4 | 496.1 Thousand USD | 2.2% |
| 2001 FY | 1.2 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 415.78 Thousand USD | 100.0% |
| Allstar Health Brands, Inc. | 2.21 Million USD | 100.0% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 16.87 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | 412.56 Thousand USD | 100.0% |
| Health Advance Inc. | 272.02 Thousand USD | 100.0% |
| HealthWarehouse.com, Inc. | 2.73 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 6.16 Million USD | 100.0% |
| MedGen, Inc. | 24.47 USD | 100.0% |
| Omni Health, Inc. | 1.84 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | 207.06 Thousand USD | 100.0% |
| Pineapple, Inc. | 8.1 Million USD | 100.0% |
| ScripsAmerica, Inc. | 1.2 Million USD | 100.0% |